IN-VITRO CULTURE OF B-LYMPHOCYTES DERIVED FROM EPSTEIN-BARR-VIRUS-ASSOCIATED POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE - CYTOKINE PRODUCTION AND EFFECT OF INTERFERON-ALPHA
P. Randhawa et al., IN-VITRO CULTURE OF B-LYMPHOCYTES DERIVED FROM EPSTEIN-BARR-VIRUS-ASSOCIATED POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE - CYTOKINE PRODUCTION AND EFFECT OF INTERFERON-ALPHA, In vitro cellular & developmental biology. Animal, 33(10), 1997, pp. 803-808
Epstein-Barr-virus-associated posttransplant lymphoproliferative disea
se ranges from transient lymphadenitis to aggressive lymphoma. This st
udy characterizes an in vitro model to study the pathogenesis of this
disease with a cell culture system. Five B-cell lines derived from pos
ttransplant lymphoproliferative disease tissue were characterized with
regard to immunophenotype, karyotype, molecular genetics, cytokine pr
oduction, and growth regulation. All cell lines expressed CD19, CD21,
CD22, CD43, and CD77, but not CD10 antigens. Immunoglobulin light chai
n restriction was seen in four of five cell lines, and cytogenetic abn
ormalities were demonstrable in three of the five. Cells proliferating
in culture contained multiple Epstein-Barr virus episomes and showed
lytic viral replication. All cell lines produced tumor necrosis factor
-beta and interleukin-10 without evidence of autocrine growth regulato
ry loops involving these cytokines. No evidence of IL-1 alpha, IL-2, I
L-4, IL-5 or IL-6 production was found by reverse transcriptase polyme
rase chain reaction. Adding 500 U IFN-alpha/ml to the culture medium r
esulted in 30% inhibition of [H-3]thymidine incorporation.